Stem cell injection for Alzheimer's disease
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial studies a new treatment for people with mild to moderate Alzheimer's disease. They take your own fat cells, turn them into stem cells, and inject them into the fluid around your brain. The hope is that these cells may help slow down memory loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 45 and 85 years old.
- You must have a diagnosis of mild to moderate Alzheimer's disease (a doctor's assessment).
- You need to have a caregiver who can come with you to study visits.
- You must be generally healthy, without other brain conditions like strokes or Parkinson's.
- No active cancer or history of cancer within the last 5 years.
- You must be able to have a small sample of fat taken from your body (like a mini liposuction) to make the stem cell treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells from donated fat tissue can help people with mild to moderate Alzheimer's disease. It combines infusions of these cells with standard care, and includes brain scans and memory tests to see if the treatment is safe and effective.
This study is a follow-up for people who already received one dose of an experimental stem-cell treatment (called RB-ADSC) for a brain condition. It tests whether giving additional doses through a small tube in the brain is safe and tolerable. If you did well in the first study, this might be an option for continued treatment.
This Phase 2 study tests whether sargramostim (a GM-CSF related medicine) is safe and can slow or improve Alzheimer’s symptoms. You might be a good fit if you have mild or moderate Alzheimer’s, positive amyloid testing, and can complete frequent visits with a close caregiver who knows you well.
This trial tests a vaccine that may help the immune system clear a protein linked to Alzheimer's disease. It is for people who do not have memory problems yet but have signs of the disease in their blood or brain scans.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This trial tests a stem cell treatment for people with early-stage Alzheimer's disease. It aims to see if the treatment can help slow memory loss or other symptoms. You must have a specific blood test showing inflammation in the body to qualify.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.